ComplianceDespite the high level of clinical efficacy and cost effectiveness of DR screening and treatment..problems remain with screening and treatment COMPLIANCE.Many people with diabetes do not access regular eye examinations and the barriers that prevent them from attending for screening are numerousFactors affecting nonadherence to recommended guidelines are numerous.They include lack of awareness that DR can lead to blindness or that severe retinopathy can be asymptomaticLimited access to eye care professionals, particularly in remote areasEnter Diagnos.CARA is a tele-ophthalmology platform which combines advanced retinal imaging with clinical image interpretation services performed by a network of ophthalmologists. CARA is a turnkey solution for primary care physicians allowing their patients to benefit from a remote ophthalmology consultation..COMPLIANCE will ultimately get better when Governments give the green light to installing the CARA systems in walk-in clinics or Pharmacies.DIAGNOS appears to be the front runner in this technology.